CDMO News
VitriVax Secures $9.9 Million Gates Foundation Grant to Advance ALTA Vaccine Technology
VitriVax, Inc., a vaccine formulation technology company, has been awarded a two-year, $9.9 million grant from the Gates Foundation. The funding will support the scale-up of the company’s Atomic Layering Thermostable Antigen and Adjuvant (ALTA) platform and prepare it for
15 October 2025